Today: 17 May 2026
Palantir shares jump on fresh $200 target as Thiel sale plan keeps traders edgy
4 March 2026
2 mins read

Palantir shares jump on fresh $200 target as Thiel sale plan keeps traders edgy

NEW YORK, March 4, 2026, 07:57 EST

  • Palantir shares picked up roughly 1.4% in premarket action
  • Rosenblatt upped its price target to $200, previously $150, while sticking with its buy rating
  • U.S. defense AI policy changes are drawing investor attention after fresh restrictions landed on rival technologies.

Shares of Palantir Technologies Inc climbed roughly 1.4% ahead of the open on Wednesday, after Rosenblatt Securities bumped its price target on the data analytics company to $200, up from $150. The firm maintained its buy rating.

The call came while the Pentagon was reassessing its approach to purchasing and deploying commercial AI, following a senior official’s warning that certain contract terms might lock down tools during combat planning. Large language models—AI trained on vast text datasets—can respond to prompts by generating answers and plans.

The vendor roster is under pressure now, too. Defense contractors are moving to drop Anthropic’s Claude, following President Donald Trump’s directive for a government-wide phase-out. The Pentagon has also labeled the company a supply-chain risk. Still, some attorneys argue the wider ban on contractors could face legal hurdles.

Reuters reported Monday that the U.S. State Department, Treasury, and Health and Human Services instructed employees to discontinue using Anthropic’s products, directing them to use alternatives including OpenAI’s ChatGPT and Google’s Gemini instead.

Palantir’s bread and butter has been government and defense contracts for years. Back in July, the U.S. Army announced plans to consolidate a slew of software deals into one enterprise contract with Palantir, potentially valued at $10 billion across a decade. Still, the Army emphasized there are no guaranteed new buys in the agreement.

Insider selling cropped up again this week. According to a Form 144 filing the SEC logged late Monday, STS Holdings II LLC—controlled by Palantir co-founder Peter Thiel—put forward plans to unload as many as 2 million Class A shares, with the total market value pegged at roughly $280 million.

Executives at the company aren’t mincing words. “If you have ever considered returning to Palantir, this is the week to do it,” Ted Mabrey, Palantir’s global head of commercial, wrote in a post, adding a Tolkien reference for alumni: “The Shire is calling.” Business Insider

Guardian Premier Solutions, a defense contractor based in San Antonio, has taken Palantir to Texas state court, accusing the company of fraud and breach of contract over a partnership program that, according to the local report, cost roughly $709,000 and failed to deliver the business referrals it promised. The report also noted that Palantir hadn’t filed a response to the suit.

Traders are eyeing whether Washington’s stricter contract guardrails mean more projects for integrators such as Palantir. Another read: the spending might just favor model providers and cloud players already wired into government channels.

Still, risks stand out. Should the Anthropic ban get rolled back or limited, the procurement shift might lose steam, and Palantir’s lofty valuation doesn’t tolerate much misstep. Defense-focused gainers often see a quick pullback from investors once the story quiets down.

Stock Market Today

  • Keyera (TSX:KEY) Shares Rise Amid Valuation Debate
    May 16, 2026, 8:01 PM EDT. Keyera (TSX:KEY) shares rose 4.2% in one day and 17.4% over a month, hitting CA$57.44. The energy infrastructure company's 1-year total shareholder return stands at nearly 40%, with 5-year returns surpassing 150%. Market consensus suggests a slight overvaluation of about 3%, pricing the fair value at CA$56, based on growth in fee-based EBITDA and dividend increases backed by long-term contracts. However, a discounted cash flow (DCF) analysis projects a much higher intrinsic value near CA$170 per share, indicating potential undervaluation. Key risks include regulatory shifts in Western Canada and acquisition integration concerns. Investors face contrasting views between near-term earnings multiples and long-term cash flow forecasts.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Snowflake edges closer to the sales floor as EY and Canva roll out “agentic” AI platform
Previous Story

Snowflake edges closer to the sales floor as EY and Canva roll out “agentic” AI platform

Why Alphabet’s Google Class C stock (GOOG) is in focus today: Trump’s power pledge and a new Waymo probe
Next Story

Why Alphabet’s Google Class C stock (GOOG) is in focus today: Trump’s power pledge and a new Waymo probe

Go toTop